🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-523931-21-00
Completed Phase I

Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants with Advanced Solid Tumors

2025-523931-21-00 · tracked via the Priya Life Science EU tracker
Sponsor
Genmab A/S
Sponsor type
Pharmaceutical company
Therapeutic area
Neoplasms
Decision date
24/03/2026
Enrollment target
77
Sites
Spain

Condition studied

Advanced Malignant Solid Tumors

Eligibility

Age group
18-64 years, 65+ years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-523931-21-00 on CTIS ↗ ← All trials in the EU